Unlocking the Secrets of FX Option Expiries: Your Guide to the 10am New York Cut on May 1st

EUR/USD- 1.0925-35 (€855m)- 1.0945-50 (€1.5bn)- 1.0975-80 (€1.1bn)- 1.0985-90 (€550m)- 1.1000 (€679m)- 1.1035-40 (€811m) USD/JPY- 133.90-00 ($1.1bn)- 135.00 ($1.3bn)- 136.00 ($826m)- 136.50-60 ($1.1bn)- 137.00 ($710m) GBP/USD- 1.2550 (£372m) AUD/USD- 0.6550-60 (A$619m)- 0.6600 (A$656m) EUR/CHF- 1.0000 (€559m) AUD/NZD- 1.0850 (A$684m) There are a couple to take note of, as highlighted in bold. The ones for EUR/USD may…

Read More

Introducing the Capacity Assessment Framework by Satpreet Singh: A Quirky and Personal Approach to Aligning Organizational Objectives

Welcome to the world of Infographics! Assessing Capacity with Organizational Objectives A Funny Look at Improving Organizational Capacity Have you ever thought about how infographics can help you assess your organization’s capacity in achieving its objectives? Well, today we’re going to dive into this quirky world and explore how utilizing infographics can improve your position…

Read More

Clever, Personable, and Unconventional: Gilead Sciences Launches Asia-Pacific Rainbow Grant 2023

Celebrating the Fifth Anniversary of the Asia Pacific Rainbow Grant Program More than US$4.5 Million Awarded to Organizations in the Asia Pacific Region Grant Program in 2023 Focuses on ‘Reducing Stigma & Improving Equity’ Celebrating a momentous occasion, Gilead Sciences marks the fifth anniversary milestone of the Asia Pacific Rainbow Grant Program, which has already…

Read More

WEF’s Future of Jobs Report 2023: A Comprehensive Look at the Changing Landscape of Employment

Embracing the Future: Pakistan’s Workforce Adapts to Emerging Opportunities and Technological Disruption Fastest Growing and Eliminating Jobs Pakistan is at a crucial juncture in its economic development, with the need to adapt to the changing landscape of job opportunities and technological disruptions. The World Economic Forum’s Future of Jobs Report 2023 highlights the importance of…

Read More

Breaking News: Astellas to Acquire Iveric Bio – A Game-Changing Deal in the World of Pharmaceuticals!

Companies to Create World-Class Ophthalmology Entity Lead Program, Avacincaptad Pegol for the Potential Treatment of Geographic Atrophy with PDUFA Goal Date of August 19, 2023 Acquisition advances Astellas’ Primary Focus on “Blindness & Regeneration” Acquisition price of US$40 per share in cash, representing a total equity value of approximately US$5.9 billion TOKYO and PARSIPPANY, N.J.,…

Read More